Alternativen zu Finasteride

A dual 5α-reductase (type I + II) inhibitor approved for benign prostatic hyperplasia and used off-label for male pattern hair loss. It suppresses DHT more deeply than finasteride (which blocks only type II), and head-to-head it beats finasteride for hair regrowth. It carries the same sexual and mood side-effect concerns as finasteride — with a much longer half-life, so any persistent effects clear more slowly. A prescription drug, not a supplement, and not a longevity drug.

A phytosterol-rich cold-pressed oil studied for prostate, hair, and cardiovascular support. The honest verdict: small RCTs show modest BPH, hair, and blood-pressure benefits — but the trials are few and tiny, and it underperforms standard drugs like tamsulosin for BPH.

A potassium-channel-opening vasodilator — originally an oral antihypertensive — whose well-documented hypertrichosis side effect made it the first FDA-approved hair-loss drug. Topical 2–5% (Rogaine) is OTC and proven in androgenetic alopecia; low-dose ORAL minoxidil (LDOM, ~0.25–5 mg) is an off-label, rapidly adopted alternative with real but generally mild cardiovascular/hypertrichosis side effects. A drug, not a supplement — and not a longevity compound.

Plant sterol that reduces BPH urinary symptoms in clinical trials and blocks intestinal cholesterol absorption.

African cherry bark extract that improves urinary flow and reduces nighttime urination in men with BPH — used clinically since the 1960s.

Herbal support for prostate health and urinary symptoms, often combined with saw palmetto for BPH.